8 completed. 8 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 8 | Completed 8 |
| Phase 2 | 1 | Completed 1 |
Follow Telangiectasis: new trials by email Literature Review of Telangiectasis trials Research Report on Telangiectasis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluate the Neurological Effects of EryDex on Subjects With A-T Dexamethasone sodium phosphate, Placebo - Ataxia Telangiectasia | Phase 3 | Completed | Quince Therapeutics S.p.A. | 105 | 2024-06-24 | 2026-04-30 |
| Effects of Pazopanib on Hereditary Hemorrhagic Telangiectasia Related Epistaxis and Anemia (Paz) Pazopanib, Placebo oral capsule - Hereditary Hemorrhagic Telangiectasia, Epistaxis | Phase 2 / Phase 3 | Completed | Cure HHT | 71 | 2023-05-08 | 2026-10-27 |
| BABH Study: Efficacy and Safety of Bevacizumab on Severe Bleedings Associated With Hemorrhagic Hereditary Telangiectasia (HHT). Bevacizumab, sodium chloride 0.9% - Rendu Osler Disease, Telangiectasia, Hereditary Hemorrhagic | Phase 3 | Completed | Hospices Civils de Lyon | 24 | 2017-09-28 | 2025-08-06 |
| ATERO : A Randomised Study With Tranexamic Acid in Epistaxis of Rendu Osler Syndrome tranexamic acid - Telangiectasia, Hereditary Hemorrhagic, Osler-Rendu Disease | Phase 3 | Completed | Hospices Civils de Lyon | 170 | 2006-09-01 | 2019-05-28 |
| Conjugate Pneumococcal Vaccine in Ataxia Telangiectasia (AT) Conjugated pneumococcal vaccine (Prevenar) - Ataxia Telangiectasia (AT) | Phase 3 | Completed | Institute of Child Health | 30 | 2006-06-01 | 2008-04-11 |
| Intravitreal Bevacizumab for Idiopathic Macular Telangiectasia Intravitreal Injection of Bevacizumab (1.25 mg/0.05ml) - Retina, Telangiectasis | Phase 3 | Completed | University of Sao Paulo | 31 | 2006-01-01 | 2008-07-23 |
| Tranexamic Acid and Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) Tranexamic acid first, than placebo, First placebo, than Tranexamic acid. - Hereditary Hemorrhagic Telangiectasia | Phase 3 | Completed | University Hospital, Saarland | 23 | 2002-03-01 | 2009-12-15 |
| Phase III Randomized, Placebo-Controlled, Crossover Study of Soy Protein Isolate for Hereditary Hemorrhagic Telangiectasia soy protein isolate - Hereditary Hemorrhagic Telangiectasia | Phase 3 | Completed | National Center for Research Resources (NCRR) | 60 | 1996-01-01 | 2005-06-24 |
Telangiectasia, Hereditary Hemorrhagic (5) · Epistaxis (3) · Anemia (2) · Ataxia Telangiectasia (2) · Disease (1) · Genetic Diseases, Inborn (1) · Hematologic Diseases (1) · Rare Diseases (1) · Retinal Neovascularization (1)
Cardiovascular Diseases (8) · Vascular Diseases (8) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (7) · Cardiovascular Abnormalities (5) · Congenital Abnormalities (5) · Hemic and Lymphatic Diseases (5) · Hemorrhagic Disorders (5) · Hemostatic Disorders (5) · Pathologic Processes (5) · Pathological Conditions, Signs and Symptoms (5) · Vascular Malformations (5) · Hematologic Diseases (4) · Hemorrhage (3) · Nose Diseases (3)
Bevacizumab (1) · Cellulose (1) · Heptavalent Pneumococcal Conjugate Vaccine (1) · Sodium Chloride (1) · Soybean Proteins (1) · Tranexamic Acid (1) · dexamethasone 21-phosphate (1) · pazopanib (1)
Hospices Civils de Lyon (2) · Cure HHT (1) · Institute of Child Health (1) · National Center for Research Resources (NCRR) (1) · Quince Therapeutics S.p.A. (1) · University Hospital, Saarland (1) · University of Sao Paulo (1)
France (2) · Germany (2) · United Kingdom (2) · United States (2) · Brazil (1) · Denmark (1) · Italy (1) · Norway (1) · Poland (1) · Spain (1) · Switzerland (1)
Dirk Thye, MD (1) · James Gossage, MD (1) · Joshua R. Korzenik (1) · Otacilio O Maia Jr, M.D. (1) · Urban W Geisthoff, Priv.-Doz. Dr.med. (1) · Walter Y Takahashi, M.D. (1)
PMID 17659962, PMID 25005464, PMID 25040799, PMID 30191360, PMID 37592715, PMID 42600624
2017 (1)